Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
复制标题
DOI：
10.1002/dad2.12048
复制
发表时间：
2020-01-01
影响因子：
5.3
通讯作者：
McCarthy, Ellen P.
中科院分区：
文献类型：
--
作者：
Jutkowitz, Eric;Bynum, Julie P. W.;McCarthy, Ellen P.
三分之一的Medicare受益人参加了Medicare Advantage（MA）。然而，很少有人知道MA受益人诊断为阿尔茨海默病（AD）和AD相关痴呆症（AD/ADRD）。MethodsWe计算了AD/ADRD诊断的患病率在2014年和2016年在三个MA计划。我们确定了被诊断患有AD/ADRD的受益人的人口统计学特征，以及他们是否在索引日期后的364天内因任何原因退出MA计划。ResultsIn 2014年和2016年，AD/ADRD诊断的总体患病率分别为5.6%和6.5%。2016年，AD/ADRD受益人平均年龄为82.4岁（SD = 7.4），61.8%为女性，患有多种合并症。到指数日期后364天，32%的AD/ADRD受益人退出了计划。2014年受益人诊断AD/ADRD的人口统计学特征与他们的2016年people.DiscussionThe患病率AD/ADRD诊断在MA低于医疗保险收费服务报告的利率。
IntroductionOne-third of Medicare beneficiaries are enrolled in Medicare Advantage (MA). Yet, little is known about MA beneficiaries diagnosed with Alzheimer's disease (AD) and AD-related dementias (AD/ADRD).MethodsWe calculated the prevalence of AD/ADRD diagnoses in 2014 and 2016 in three MA plans. We determined the demographic characteristics of beneficiaries diagnosed with AD/ADRD, and whether they disenrolled from the MA plan for any reason within 364 days from the index date.ResultsIn 2014 and 2016, the overall prevalence of AD/ADRD diagnoses was 5.6% and 6.5%, respectively. In 2016, AD/ADRD beneficiaries were on average 82.4 (SD = 7.4) years of age, 61.8% female, and had multiple comorbidities. By 364 days post-index date, 32% of beneficiaries with AD/ADRD had disenrolled from their plan. The demographic characteristics of 2014 beneficiaries with diagnosed AD/ADRD were similar to their 2016 counterparts.DiscussionThe prevalence of AD/ADRD diagnosis in MA is lower than rates reported in Medicare fee-for-service.